Cancer Research Meeting Calendar  Metabolism and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryan, K. M.
Right arrow Articles by Vousden, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryan, K. M.
Right arrow Articles by Vousden, K. H.
[Cancer Research 64, 4415-4418, July 1, 2004]
© 2004 American Association for Cancer Research


Advances in Brief

Loss of Nuclear Factor-{kappa}B Is Tumor Promoting but Does Not Substitute for Loss of p53

Kevin M. Ryan1,3, Jim O’Prey1 and Karen H. Vousden2,3

1 Tumor Cell Death Laboratory and 2 Tumor Suppression Laboratory, Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Glasgow, United Kingdom, and 3 Regulation of Cell Growth Laboratory, National Cancer Institute at Frederick, Frederick, Maryland

Inactivation of apoptotic pathways is a common event in cancer. Two transcription factors that regulate apoptosis during tumorigenesis are p53 and nuclear factor (NF)-{kappa}B. Although NF-{kappa}B is generally considered a suppressor of cell death, we showed previously that NF-{kappa}B can contribute to p53-induced death. Here, we show that loss of p65, a critical subunit of NF-{kappa}B, can cause resistance to different agents that signal death through p53. Loss of p65 also enhances tumorigenesis induced by E1a and Ras. Unlike loss of p53, however, loss of p65 does not cause anchorage-independent growth or enable tumor development following expression of a single oncogene. These findings reaffirm the role of NF-{kappa}B in p53-induced death but show that its loss does not substitute for loss of p53 in tumor development. Moreover, this indicates that, although perhaps central to p53 function, loss of the ability to induce programmed cell death does not completely inactivate p53’s tumor-suppressive effects.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
T. Copetti, C. Bertoli, E. Dalla, F. Demarchi, and C. Schneider
p65/RelA Modulates BECN1 Transcription and Autophagy
Mol. Cell. Biol., May 15, 2009; 29(10): 2594 - 2608.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. D. Minsavage and J. F. Dillman III
Bifunctional Alkylating Agent-Induced p53 and Nonclassical Nuclear Factor {kappa}B Responses and Cell Death Are Altered by Caffeic Acid Phenethyl Ester: A Potential Role for Antioxidant/Electrophilic Response-Element Signaling
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 202 - 212.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. V. Gurova, J. E. Hill, C. Guo, A. Prokvolit, L. G. Burdelya, E. Samoylova, A. V. Khodyakova, R. Ganapathi, M. Ganapathi, N. D. Tararova, et al.
Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-{kappa}B-dependent mechanism of p53 suppression in tumors
PNAS, November 29, 2005; 102(48): 17448 - 17453.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.